The Charter of the French Language and its regulations govern the consultation of English-language content.


2601 Chemin de la Canardière
Québec (Québec)
G1J 2G3
Canada
Professeure titulaire, École de psychologie, Université Laval
Chercheure, CERVO
Axe de recherche:
Neurosciences cliniques et cognitives
sommeil, insomnie, EEG, PSG, potentiels évoqués cognitifs, rêves, éveil
Célyne Bastien s’intéresse aux aspects psychologiques et physiologiques de l’insomnie afin de comprendre ses effets sur les personnes qui en souffrent et de trouver des moyens de les traiter. Elle s’intéresse plus particulièrement aux mécanismes de protection du sommeil (qui permettent de rester endormi) et compare la qualité objective (mesurée en laboratoire) et la qualité subjective (rapportée par les individus) de bons dormeurs et d’insomniaques.
Pre Bastien étudie l’activité du cerveau durant le sommeil par électroencéphalogramme, ce qui lui permet d’identifier des caractéristiques du sommeil des insomniaques qui le distingue du sommeil des bons dormeurs. Des mesures neurophysiologiques et neuropsychologiques sont également utilisées pour comparer la qualité objective et subjective du sommeil, et sa perception parfois erronée. Ces mesures permettent des interventions personnalisées auprès des personnes afin de les aider à adopter des comportements et attitudes qui favorisent le sommeil.
Elle a dirigé des études montrant que le cerveau des personnes insomniaques demeurait dans un état d’hypervigilance durant le sommeil, et ces personness répondaient différemment à des stimulations (sonores ou visuelles) en situation de sommeil, mais aussi d’éveil.
L’équipe de la Pre Bastien s’est aussi récemment intéressé aux rêves des personnes insomniaques, et ces études ont montré que les bons dormeurs faisaient des rêves plus positifs, associés à des sentiments de joie et de bonheur, alors que les personnes insomniaques rapportaient des rêves plus négatifs. Cette dernière découverte suggère que des techniques de gestion des rêves pourraient s’avérer intéressantes pour favoriser la qualité du sommeil.
Pre Bastien s’intéresse également aux liens entre les caractéristiques du sommeil et la capacité d’apprentissage et la fonction mentale au réveil, ainsi qu’aux liens entre l’insomnie et d’autres troubles psychiatriques ou de l’humeur, comme la dépression.
Un autre intérêt de la Pre Bastien est le lien entre vieillissement et qualité du sommeil.
Aspects psychophysiologiques du sommeil; microstructure et méthodes quantitatives (analyse spectrale) de l’électroencéphalogramme (EEG); insomnie; activation corticale et hypervigilance; étude des potentiels évoqués cognitifs en sommeil et à l’éveil; conséquences diurnes et traitement comportemental cognitif de l’insomnie; perception erronée des états de conscience; vieillissement, sommeil et cognition normale et pathologique.
Photo de septembre 2016
Après des stages postdoctoraux à l’Hôpital du Sacré-Cœur de Montréal et au Centre des troubles du sommeil du Centre de recherche de l’Institut universitaire en santé mentale de Québec, madame Bastien occupe, de 1999 à 2001, un poste d’attachée de recherche à l’École de psychologie. Chercheure–boursière du FRSQ en 2001, elle est ensuite nommée professeure adjointe sous octroi en 2003 grâce à une subvention des nouveaux chercheurs des IRSC. En 2005, elle accède au titre de professeure agrégée sous octroi et obtient un poste de professeure régulière en 2006. Madame Bastien est nommée professeure titulaire en juin 2009. Spécialiste de l’utilisation des potentiels évoqués cognitifs en état de sommeil et de veille, elle dirige présentement des travaux subventionnés par les IRSC portant sur la mesure de l’activation corticale chez les personnes souffrant d’insomnie. Son expérience en mesures quantitatives de l’EEG et en événements phasiques en sommeil est mise à profit sur plusieurs projets de recherche sur lesquels elle collabore, notamment sur le travail de nuit et les rythmes circadiens (IRSC). Elle a collaboré également à d’autres projets subventionnés par le NIH et le ministère des Affaires indiennes sur les effets neurologiques et neurophysiologiques de l’exposition aux BPC et au mercure chez les enfants. Elle occupe les postes de vice-présidente (recherche) (2010-2013) et de responsable des communications de la Société canadienne du sommeil (2013-2016) et directrice des programmes de 1er cycle à l’École de psychologie (2011-2015).
Annie Vallières; Alric Pappathomas; Séverine de Billy Garnier; Chantal Mérette; Julie Carrier; Tyna Paquette; Célyne H Bastien
Behavioural therapy for shift work disorder improves shift workers’ sleep, sleepiness and mental health: A pilot randomised control trial Article de journal
Dans: J Sleep Res, vol. 33, no 6, p. e14162, 2024, ISSN: 1365-2869.
@article{pmid38443322,
title = {Behavioural therapy for shift work disorder improves shift workers' sleep, sleepiness and mental health: A pilot randomised control trial},
author = {Annie Vallières and Alric Pappathomas and Séverine de Billy Garnier and Chantal Mérette and Julie Carrier and Tyna Paquette and Célyne H Bastien},
doi = {10.1111/jsr.14162},
issn = {1365-2869},
year = {2024},
date = {2024-12-01},
journal = {J Sleep Res},
volume = {33},
number = {6},
pages = {e14162},
abstract = {The present study evaluates the efficacy of behavioural therapy adapted for shift work disorder with a randomised control design in a healthcare population. Forty-three night shift workers (m. age: 34 years; 77% women) experiencing shift work disorder were randomised to either the behavioural therapy for shift work disorder (BT-SWD) or a waiting-list control group offered after the waiting period. Participants completed questionnaires on insomnia, sleepiness and mental health pre- and post-treatment, pre- and post-waiting, and at follow-up, and a sleep diary. As night shift workers alternate between sleeping during the day after their night shifts and transitioning to nighttime sleep on days off, insomnia severity and sleep variables were analysed for daytime and nighttime sleep. The BT-SWD involved sleep restriction therapy, stimulus control and fixed sleep periods in the dark. Statistical analyses were performed under intent-to-treat and per-protocol approaches. Repeated-measures two-way ANCOVA analysis, controlling for age, sex and pre-treatment daytime total sleep time, was performed with Bonferroni corrections, and between-group effect sizes computed. Fourteen participants dropped out after randomisation. Under the intent-to-treat analysis, BT-SWD participants had a significant greater decrease in daytime insomnia severity and an increase in daytime total sleep time at post-treatment than the control group, with large between-group effect sizes (-1.25 and 0.89). These corresponding results were also significant with large effect sizes under the per-protocol analysis. Sleepiness, anxiety and depression levels improved at post-treatment and maintained at follow-up when the BT-SWD treated controls were added to the BT-SWD group. The behavioural therapy for shift work disorder can be used to improve the sleep and mental health of healthcare night workers.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Dave Laroche; Hans Ivers; Celyne H Bastien; Annie Vallières
Predictability of sleep in insomnia: sleep patterns of patients from a sleep psychology clinic Article de journal
Dans: J Sleep Res, p. e14369, 2024, ISSN: 1365-2869.
@article{pmid39327793,
title = {Predictability of sleep in insomnia: sleep patterns of patients from a sleep psychology clinic},
author = {Dave Laroche and Hans Ivers and Celyne H Bastien and Annie Vallières},
doi = {10.1111/jsr.14369},
issn = {1365-2869},
year = {2024},
date = {2024-09-01},
journal = {J Sleep Res},
pages = {e14369},
abstract = {The present study aims at identifying sleep patterns in insomnia in a clinical sample using three strategies to define poor nights. Sleep diaries and self-reported questionnaires were collected from 77 clinical patients with insomnia. The conditional probabilities of observing a poor night after 1, 2, or 3 consecutive poor nights were computed according to three strategies with same criteria for sleep onset latency, wake after sleep onset, and sleep efficiency, but varying criterion for total sleep time. Latent profile analyses were conducted to derive sleep patterns. Uni- and multivariate analyses were conducted to characterise the sleep patterns identified. A total of 1586 nights were analysed. The strategy used significantly influenced the average percentage of reported poor nights. Two to three sleep patterns were derived per strategy. Within each strategy, sleep patterns differed from each other on sleep variables and night-to-night variability. Results suggest the existence of sleep patterns in insomnia among individuals consulting in psychological clinics. Adding a total sleep time of 6-h cut-off as a criterion to define poor nights increases the accuracy of the strategy to define poor night and allows to identify sleep patterns of poor nights in insomnia.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Claire André; Marie-Ève Martineau-Dussault; Andrée-Ann Baril; Nicola Andrea Marchi; Véronique Daneault; Dominique Lorrain; Carol Hudon; Célyne H Bastien; Dominique Petit; Cynthia Thompson; Judes Poirier; Jacques Montplaisir; Nadia Gosselin; Julie Carrier
Reduced rapid eye movement sleep in late middle-aged and older apolipoprotein E ɛ4 allele carriers Article de journal
Dans: Sleep, vol. 47, no 7, 2024, ISSN: 1550-9109.
@article{pmid38634644,
title = {Reduced rapid eye movement sleep in late middle-aged and older apolipoprotein E ɛ4 allele carriers},
author = {Claire André and Marie-Ève Martineau-Dussault and Andrée-Ann Baril and Nicola Andrea Marchi and Véronique Daneault and Dominique Lorrain and Carol Hudon and Célyne H Bastien and Dominique Petit and Cynthia Thompson and Judes Poirier and Jacques Montplaisir and Nadia Gosselin and Julie Carrier},
doi = {10.1093/sleep/zsae094},
issn = {1550-9109},
year = {2024},
date = {2024-07-01},
journal = {Sleep},
volume = {47},
number = {7},
abstract = {STUDY OBJECTIVES: Apolipoprotein E ɛ4 (APOE4) is the strongest genetic risk factor for Alzheimer's disease (AD). In addition, APOE4 carriers may exhibit sleep disturbances, but conflicting results have been reported, such that there is no clear consensus regarding which aspects of sleep are impacted. Our objective was to compare objective sleep architecture between APOE4 carriers and non-carriers, and to investigate the modulating impact of age, sex, cognitive status, and obstructive sleep apnea (OSA).nnMETHODS: A total of 198 dementia-free participants aged >55 years old (mean age: 68.7 ± 8.08 years old, 40.91% women, 41 APOE4 carriers) were recruited in this cross-sectional study. They underwent polysomnography, APOE4 genotyping, and a neuropsychological evaluation. ANCOVAs assessed the effect of APOE4 status on sleep architecture, controlling for age, sex, cognitive status, and the apnea-hypopnea index. Interaction terms were added between APOE4 status and covariates.nnRESULTS: Rapid eye movement (REM) sleep percentage (F = 9.95, p = .002, ηp2 = 0.049) and duration (F = 9.23, p = .003, ηp2 = 0.047) were lower in APOE4 carriers. The results were replicated in a subsample of 112 participants without moderate-to-severe OSA. There were no significant interactions between APOE4 status and age, sex, cognitive status, and OSA in the whole sample.nnCONCLUSIONS: Our results show that APOE4 carriers exhibit lower REM sleep duration, including in cognitively unimpaired individuals, possibly resulting from early neurodegenerative processes in regions involved in REM sleep generation and maintenance.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Célyne H Bastien; Ellemarije Altena
Insomnia gone in one week, without medication: too good to be true? Article de journal
Dans: Sleep, vol. 47, no 6, 2024, ISSN: 1550-9109.
@article{pmid38597884,
title = {Insomnia gone in one week, without medication: too good to be true?},
author = {Célyne H Bastien and Ellemarije Altena},
doi = {10.1093/sleep/zsae092},
issn = {1550-9109},
year = {2024},
date = {2024-06-01},
journal = {Sleep},
volume = {47},
number = {6},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Julia-Pizzamiglio Delage; Jeannie Côté; William-Girard Journault; Alexandre Lemyre; Célyne H Bastien
The relationships between insomnia, nightmares, and dreams: A systematic review Article de journal
Dans: Sleep Med Rev, vol. 75, p. 101931, 2024, ISSN: 1532-2955.
@article{pmid38733767,
title = {The relationships between insomnia, nightmares, and dreams: A systematic review},
author = {Julia-Pizzamiglio Delage and Jeannie Côté and William-Girard Journault and Alexandre Lemyre and Célyne H Bastien},
doi = {10.1016/j.smrv.2024.101931},
issn = {1532-2955},
year = {2024},
date = {2024-06-01},
journal = {Sleep Med Rev},
volume = {75},
pages = {101931},
abstract = {Insomnia and nightmares are both prevalent and debilitating sleep difficulties. The present systematic review aims to document the relationships between insomnia and nightmares in individuals without a concomitant psychopathology. The relationships between insomnia and dreams are also addressed. PsycINFO and Medline were searched for papers published in English or French from 1970 to March 2023. Sixty-seven articles were included for review. Most results support positive relationships between insomnia variables and nightmare variables in individuals with insomnia, individuals with nightmares, the general population, students, children and older adults, and military personnel and veterans. These positive relationships were also apparent in the context of the COVID-19 pandemic. Some psychological interventions, such as Imagery Rehearsal Therapy, might be effective in alleviating both nightmares and insomnia symptoms. Regarding the relationships between insomnia and dreams, compared with controls, the dreams of individuals with insomnia are characterized by more negative contents and affects. The results show that insomnia and nightmares are connected and may be mutually aggravating. A model is proposed to explain how insomnia might increase the likelihood of experiencing nightmares, and how nightmares can in turn lead to sleep loss and nonrestorative sleep.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Mikael Demers Verreault; Élyse Granger; Xavier Neveu; Julia Pizzamiglio Delage; Célyne H Bastien; Annie Vallières
The effectiveness of stimulus control in cognitive behavioural therapy for insomnia in adults: A systematic review and network meta-analysis Article de journal
Dans: J Sleep Res, vol. 33, no 3, p. e14008, 2024, ISSN: 1365-2869.
@article{pmid37586843,
title = {The effectiveness of stimulus control in cognitive behavioural therapy for insomnia in adults: A systematic review and network meta-analysis},
author = {Mikael Demers Verreault and Élyse Granger and Xavier Neveu and Julia Pizzamiglio Delage and Célyne H Bastien and Annie Vallières},
doi = {10.1111/jsr.14008},
issn = {1365-2869},
year = {2024},
date = {2024-05-01},
journal = {J Sleep Res},
volume = {33},
number = {3},
pages = {e14008},
abstract = {Stimulus control is part of the widely used cognitive behavioural therapy for insomnia. However, there is a lack of knowledge about its mechanisms of action and effectiveness when used alone. This systematic review with network meta-analysis aimed to evaluate stimulus control efficacy when used alone compared with cognitive behavioural therapy for insomnia or its components. The review also documented stimulus control mechanisms of action proposed by the authors. A search was conducted in several bibliographic databases (MEDLINE, PsycINFO, Embase, CINAHL, Psychology Behavioural Sciences Collection, Web of Science, and Cochrane Library) and in two registers from 1972 to June 2022. Randomised studies with adult participants presenting a diagnosis of insomnia and including at least one stimulus control instruction in a treatment group were included. Risk of bias was assessed with the Quality Assessment of Controlled Intervention Studies. Twenty-three studies were included and three network meta-analyses were conducted. The quality of included studies was generally poor. Results indicate that stimulus control is an effective intervention to improve insomnia compared with control conditions. Not all stimulus control instructions seem essential, especially those known to recondition the bedroom for sleep. The review challenges the classical conditioning hypothesis. Results should be interpreted cautiously given the small number of studies included, bias risk, and inconsistencies in the network meta-analysis. Rigorous research is needed in evaluating stimulus control efficacy and mechanisms.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Dieter Riemann; Colin A Espie; Ellemarije Altena; Erna Sif Arnardottir; Chiara Baglioni; Claudio L A Bassetti; Celyne Bastien; Natalija Berzina; Bjørn Bjorvatn; Dimitris Dikeos; Leja Dolenc Groselj; Jason G Ellis; Diego Garcia-Borreguero; Pierre A Geoffroy; Michaela Gjerstad; Marta Gonçalves; Elisabeth Hertenstein; Kerstin Hoedlmoser; Tuuliki Hion; Brigitte Holzinger; Karolina Janku; Markus Jansson-Fröjmark; Heli Järnefelt; Susanna Jernelöv; Poul Jørgen Jennum; Samson Khachatryan; Lukas Krone; Simon D Kyle; Jaap Lancee; Damien Leger; Adrian Lupusor; Daniel Ruivo Marques; Christoph Nissen; Laura Palagini; Tiina Paunio; Lampros Perogamvros; Dirk Pevernagie; Manuel Schabus; Tamar Shochat; Andras Szentkiralyi; Eus Van Someren; Annemieke van Straten; Adam Wichniak; Johan Verbraecken; Kai Spiegelhalder
The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023 Article de journal
Dans: J Sleep Res, vol. 32, no 6, p. e14035, 2023, ISSN: 1365-2869.
@article{pmid38016484,
title = {The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023},
author = {Dieter Riemann and Colin A Espie and Ellemarije Altena and Erna Sif Arnardottir and Chiara Baglioni and Claudio L A Bassetti and Celyne Bastien and Natalija Berzina and Bjørn Bjorvatn and Dimitris Dikeos and Leja Dolenc Groselj and Jason G Ellis and Diego Garcia-Borreguero and Pierre A Geoffroy and Michaela Gjerstad and Marta Gonçalves and Elisabeth Hertenstein and Kerstin Hoedlmoser and Tuuliki Hion and Brigitte Holzinger and Karolina Janku and Markus Jansson-Fröjmark and Heli Järnefelt and Susanna Jernelöv and Poul Jørgen Jennum and Samson Khachatryan and Lukas Krone and Simon D Kyle and Jaap Lancee and Damien Leger and Adrian Lupusor and Daniel Ruivo Marques and Christoph Nissen and Laura Palagini and Tiina Paunio and Lampros Perogamvros and Dirk Pevernagie and Manuel Schabus and Tamar Shochat and Andras Szentkiralyi and Eus Van Someren and Annemieke van Straten and Adam Wichniak and Johan Verbraecken and Kai Spiegelhalder},
doi = {10.1111/jsr.14035},
issn = {1365-2869},
year = {2023},
date = {2023-12-01},
journal = {J Sleep Res},
volume = {32},
number = {6},
pages = {e14035},
abstract = {Progress in the field of insomnia since 2017 necessitated this update of the European Insomnia Guideline. Recommendations for the diagnostic procedure for insomnia and its comorbidities are: clinical interview (encompassing sleep and medical history); the use of sleep questionnaires and diaries (and physical examination and additional measures where indicated) (A). Actigraphy is not recommended for the routine evaluation of insomnia (C), but may be useful for differential-diagnostic purposes (A). Polysomnography should be used to evaluate other sleep disorders if suspected (i.e. periodic limb movement disorder, sleep-related breathing disorders, etc.), treatment-resistant insomnia (A) and for other indications (B). Cognitive-behavioural therapy for insomnia is recommended as the first-line treatment for chronic insomnia in adults of any age (including patients with comorbidities), either applied in-person or digitally (A). When cognitive-behavioural therapy for insomnia is not sufficiently effective, a pharmacological intervention can be offered (A). Benzodiazepines (A), benzodiazepine receptor agonists (A), daridorexant (A) and low-dose sedating antidepressants (B) can be used for the short-term treatment of insomnia (≤ 4 weeks). Longer-term treatment with these substances may be initiated in some cases, considering advantages and disadvantages (B). Orexin receptor antagonists can be used for periods of up to 3 months or longer in some cases (A). Prolonged-release melatonin can be used for up to 3 months in patients ≥ 55 years (B). Antihistaminergic drugs, antipsychotics, fast-release melatonin, ramelteon and phytotherapeutics are not recommended for insomnia treatment (A). Light therapy and exercise interventions may be useful as adjunct therapies to cognitive-behavioural therapy for insomnia (B).},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Ellemarije Altena; Jason Ellis; Nathalie Camart; Kelly Guichard; Célyne Bastien
Mechanisms of cognitive behavioural therapy for insomnia Article de journal
Dans: J Sleep Res, vol. 32, no 6, p. e13860, 2023, ISSN: 1365-2869.
@article{pmid36866434,
title = {Mechanisms of cognitive behavioural therapy for insomnia},
author = {Ellemarije Altena and Jason Ellis and Nathalie Camart and Kelly Guichard and Célyne Bastien},
doi = {10.1111/jsr.13860},
issn = {1365-2869},
year = {2023},
date = {2023-12-01},
journal = {J Sleep Res},
volume = {32},
number = {6},
pages = {e13860},
abstract = {Although much is known now about behavioural, cognitive and physiological consequences of insomnia, little is known about changes after cognitive behavioural therapy for insomnia on these particular factors. We here report baseline findings on each of these factors in insomnia, after which we address findings on their changes after cognitive behavioural therapy. Sleep restriction remains the strongest determinant of insomnia treatment success. Cognitive interventions addressing dysfunctional beliefs and attitudes about sleep, sleep-related selective attention, worry and rumination further drive effectiveness of cognitive behavioural therapy for insomnia. Future studies should focus on physiological changes after cognitive behavioural therapy for insomnia, such as changes in hyperarousal and brain activity, as literature on these changes is sparse. We introduce a detailed clinical research agenda on how to address this topic.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Claire André; Marie-Ève Martineau-Dussault; Véronique Daneault; Hélène Blais; Sonia Frenette; Dominique Lorrain; Carol Hudon; Célyne Bastien; Dominique Petit; Alexandre Lafrenière; Cynthia Thompson; Jacques Montplaisir; Nadia Gosselin; Julie Carrier
REM sleep is associated with the volume of the cholinergic basal forebrain in aMCI individuals Article de journal
Dans: Alzheimers Res Ther, vol. 15, no 1, p. 151, 2023, ISSN: 1758-9193.
@article{pmid37684650,
title = {REM sleep is associated with the volume of the cholinergic basal forebrain in aMCI individuals},
author = {Claire André and Marie-Ève Martineau-Dussault and Véronique Daneault and Hélène Blais and Sonia Frenette and Dominique Lorrain and Carol Hudon and Célyne Bastien and Dominique Petit and Alexandre Lafrenière and Cynthia Thompson and Jacques Montplaisir and Nadia Gosselin and Julie Carrier},
doi = {10.1186/s13195-023-01265-y},
issn = {1758-9193},
year = {2023},
date = {2023-09-01},
journal = {Alzheimers Res Ther},
volume = {15},
number = {1},
pages = {151},
abstract = {BACKGROUND: Rapid-eye movement (REM) sleep highly depends on the activity of cholinergic basal forebrain (BF) neurons and is reduced in Alzheimer's disease. Here, we investigated the associations between the volume of BF nuclei and REM sleep characteristics, and the impact of cognitive status on these links, in late middle-aged and older participants.nnMETHODS: Thirty-one cognitively healthy controls (66.8 ± 7.2 years old, 13 women) and 31 participants with amnestic Mild Cognitive Impairment (aMCI) (68.3 ± 8.8 years old, 7 women) were included in this cross-sectional study. All participants underwent polysomnography, a comprehensive neuropsychological assessment and Magnetic Resonance Imaging examination. REM sleep characteristics (i.e., percentage, latency and efficiency) were derived from polysomnographic recordings. T1-weighted images were preprocessed using CAT12 and the DARTEL algorithm, and we extracted the gray matter volume of BF regions of interest using a probabilistic atlas implemented in the JuBrain Anatomy Toolbox. Multiple linear regressions were performed between the volume of BF nuclei and REM sleep characteristics controlling for age, sex and total intracranial volume, in the whole cohort and in subgroups stratified by cognitive status.nnRESULTS: In the whole sample, lower REM sleep percentage was significantly associated to lower nucleus basalis of Meynert (Ch4) volume (β = 0.32, p = 0.009). When stratifying the cohort according to cognitive status, lower REM sleep percentage was significantly associated to both lower Ch4 (β = 0.48, p = 0.012) and total BF volumes (β = 0.44, p = 0.014) in aMCI individuals, but not in cognitively unimpaired participants. No significant associations were observed between the volume of the BF and wake after sleep onset or non-REM sleep variables.nnDISCUSSION: These results suggest that REM sleep disturbances may be an early manifestation of the degeneration of the BF cholinergic system before the onset of dementia, especially in participants with mild memory deficits.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Jesse D Cook; Matt K P Gratton; Amy M Bender; Penny Werthner; Doug Lawson; Charles R Pedlar; Courtney Kipps; Celyne H Bastien; Charles H Samuels; Jonathan Charest
Sleep Health, Individual Characteristics, Lifestyle Factors, and Marathon Completion Time in Marathon Runners: A Retrospective Investigation of the 2016 London Marathon Article de journal
Dans: Brain Sci, vol. 13, no 9, 2023, ISSN: 2076-3425.
@article{pmid37759947,
title = {Sleep Health, Individual Characteristics, Lifestyle Factors, and Marathon Completion Time in Marathon Runners: A Retrospective Investigation of the 2016 London Marathon},
author = {Jesse D Cook and Matt K P Gratton and Amy M Bender and Penny Werthner and Doug Lawson and Charles R Pedlar and Courtney Kipps and Celyne H Bastien and Charles H Samuels and Jonathan Charest},
doi = {10.3390/brainsci13091346},
issn = {2076-3425},
year = {2023},
date = {2023-09-01},
journal = {Brain Sci},
volume = {13},
number = {9},
abstract = {Despite sleep health being critically important for athlete performance and well-being, sleep health in marathoners is understudied. This foundational study explored relations between sleep health, individual characteristics, lifestyle factors, and marathon completion time. Data were obtained from the 2016 London Marathon participants. Participants completed the Athlete Sleep Screening Questionnaire (ASSQ) along with a brief survey capturing individual characteristics and lifestyle factors. Sleep health focused on the ASSQ sleep difficulty score (SDS) and its components. Linear regression computed relations among sleep, individual, lifestyle, and marathon variables. The analytic sample (N = 943) was mostly male (64.5%) and young adults (66.5%). A total of 23.5% of the sample reported sleep difficulties (SDS ≥ 8) at a severity warranting follow-up with a trained sleep provider. Middle-aged adults generally reported significantly worse sleep health characteristics, relative to young adults, except young adults reported significantly longer sleep onset latency (SOL). Sleep tracker users reported worse sleep satisfaction. Pre-bedtime electronic device use was associated with longer SOL and longer marathon completion time, while increasing SOL was also associated with longer marathon completion. Our results suggest a deleterious influence of pre-bedtime electronic device use and sleep tracker use on sleep health in marathoners. Orthosomnia may be a relevant factor in the relationship between sleep tracking and sleep health for marathoners.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
